MD2876C2 - Biostimulating remedy of the locomotor system - Google Patents

Biostimulating remedy of the locomotor system

Info

Publication number
MD2876C2
MD2876C2 MDA20040150A MD20040150A MD2876C2 MD 2876 C2 MD2876 C2 MD 2876C2 MD A20040150 A MDA20040150 A MD A20040150A MD 20040150 A MD20040150 A MD 20040150A MD 2876 C2 MD2876 C2 MD 2876C2
Authority
MD
Moldova
Prior art keywords
remedy
biostimulating
locomotor system
embryo
efficient
Prior art date
Application number
MDA20040150A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD2876B1 (en
Inventor
Христофор ПАНЯ
Original Assignee
Христофор ПАНЯ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Христофор ПАНЯ filed Critical Христофор ПАНЯ
Priority to MDA20040150A priority Critical patent/MD2876C2/en
Priority to PCT/MD2005/000028 priority patent/WO2006004385A1/en
Publication of MD2876B1 publication Critical patent/MD2876B1/en
Publication of MD2876C2 publication Critical patent/MD2876C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Developmental Biology & Embryology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention refers to medicine, namely to traumatology, and is meant for treatment of fractures, pseudoarthrosis, posttraumatic osteomyelitis and degenerative-dystrophic diseases of the osteoarticular system.Summary of the invention consists in that the buostimulating remedy comprises in an efficient quantity primary tissue culture, obtained from the locomotor system of the pig embryo at the age of 35…39 days with addition of embryo blood cells in a quantity of 5,5…9,5% of its weight. The efficient quantity of primary cells may constitute 50 mln.
MDA20040150A 2004-06-15 2004-06-15 Biostimulating remedy of the locomotor system MD2876C2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MDA20040150A MD2876C2 (en) 2004-06-15 2004-06-15 Biostimulating remedy of the locomotor system
PCT/MD2005/000028 WO2006004385A1 (en) 2004-06-15 2005-06-14 Bio-stimulating medicinal agent for locomotor apparatus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20040150A MD2876C2 (en) 2004-06-15 2004-06-15 Biostimulating remedy of the locomotor system

Publications (2)

Publication Number Publication Date
MD2876B1 MD2876B1 (en) 2005-10-31
MD2876C2 true MD2876C2 (en) 2006-07-31

Family

ID=35229977

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20040150A MD2876C2 (en) 2004-06-15 2004-06-15 Biostimulating remedy of the locomotor system

Country Status (2)

Country Link
MD (1) MD2876C2 (en)
WO (1) WO2006004385A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110951894B (en) * 2020-01-01 2021-03-16 华中农业大学 SNP molecular marker related to pig initial-mating day-age character

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD1585G2 (en) * 2000-05-24 2001-07-31 CIOBANU Pavel Biostimulating remedy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1176896A1 (en) * 1983-10-17 1985-09-07 Горьковский медицинский институт им.С.М.Кирова Method of surgical treatment of osteomyelitis
DE3775363D1 (en) * 1986-10-22 1992-01-30 Biotechnolog Forschung Gmbh GROWTH-STIMULATING MATERIAL, MANUFACTURING PROCESS AND THERAPEUTIC COMPOSITION.
SU1729500A1 (en) * 1988-04-26 1992-04-30 Алма-Атинский Государственный медицинский институт Method for osteoplasty
RU2225212C2 (en) * 2001-09-27 2004-03-10 Малахов Олег Алексеевич Method for stimulating distraction regenerate

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD1585G2 (en) * 2000-05-24 2001-07-31 CIOBANU Pavel Biostimulating remedy

Also Published As

Publication number Publication date
WO2006004385A1 (en) 2006-01-12
MD2876B1 (en) 2005-10-31

Similar Documents

Publication Publication Date Title
Khazaei et al. New findings on biological actions and clinical applications of royal jelly: a review
ECSP055739A (en) NEUTRALIZATION ANTIBODIES AGAINST GDF-8, AND ITS USES
WO2003096990A3 (en) Protein cages for the delivery of medical imaging and therapy
BRPI0414455A (en) Methods for Using Regenerative Cells to Treat Peripheral Vascular Disease and Related Disorders
CR8380A (en) METHODS FOR PREPARING AND USING NEW DEVELOPMENTS OF MOTHER CELLS AND THEIR ASSEMBLIES
MX2007007032A (en) Aminopyrimidine compounds and methods of use.
MX2007004551A (en) Thiadiazole compounds and methods of use.
NZ606825A (en) Methods and compositions for treating complement-associated disorders
ATE489956T1 (en) FORMULATIONS CONTAINING SALICYLATES AND THEIR USE IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
MXPA05008445A (en) Use of umbilical cord blood to treat individuals having a disease, disorder or condition.
UA81676C2 (en) Compositionss for treating infection in cattle and swine
TW200637618A (en) Compositions and methods for treating conditions of the nail unit
ITMI20041550A1 (en) USE OF PROBIOTIC BACTERIA FOR THE PREPARATION OF TOPICAL COMPOSITIONS FOR THE PROTECTION OF THE EPIDERMIS
DE602004016729D1 (en) 1-PHENYLALKANCARBONIC ACID DERIVATIVES FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES
NO20070854L (en) Human monoclonal antibodies to human IL-4.
MX2008000838A (en) Compositions and methods for treating gram positive bacterial infection in a mammalian subject.
PL378238A1 (en) Biaromatic compounds which activate ppar-gama type receptors, and use thereof in cosmetic or pharmaceutical compositions
BRPI0418157A (en) allogeneic tumor therapy
EA200600921A1 (en) METHODS AND COMPOSITIONS WITH THE USE OF TALIDOMIDE FOR THE TREATMENT AND MANAGEMENT OF CANCER AND OTHER DISEASES
EP1543158A4 (en) Regulated aptamer therapeutics
ATE535231T1 (en) METHOD FOR PRODUCING POLY-ICLC AND USE THEREOF
NO20076405L (en) Use of 24-nor-UDCA
MD2876C2 (en) Biostimulating remedy of the locomotor system
BR0109928A (en) Use of an attenuated herpes virus, and, method for stimulating an immune response in a human or animal individual, or for treating or preventing a pathogenic infection or cancer in a human or animal individual.
TR200200278T2 (en) Calcilitic compositions

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees